Physician

Harry Douglas Vildibill, M.D.

According to 2025 Medicare claims, Harry Vildibill, M.D. (NPI: 1194702290) practices general surgery in the Albany, GA market, with the plurality of this provider's patient population coming from Dougherty, GA. This provider's primary affiliated billing organization is SURGICAL ASSOCIATES OF ALBANY PC (NPI: 1447284781) and primary practice location at 31701-1954.

Vildibill's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 388 traditional Medicare patients, billed 920 HCPCS/CPT codes, and received $112,595 in Medicare payments. The top billing code was 47563 (Removal of gallbladder with x-ray study of bile ducts using an endoscope). Part D data shows 982 prescription claims across 388 beneficiaries totaling $31,552 in drug costs, led by Clenpiq (Sod Picosulf/Mag Ox/Citric Ac). 2020 DME data shows 31 claims. Open Payments data shows 5 records totaling $169. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $155,187 to $112,595. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,571 and ending at $2,692.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	572	1,353	$155,187
2016	578	1,462	$178,358
2017	501	1,238	$141,109
2018	520	1,435	$177,095
2019	532	1,416	$184,260
2020	448	1,049	$125,067
2021	408	1,042	$130,823
2022	414	1,088	$122,746
2023	354	935	$114,572
2024	388	920	$112,595

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	277	875	$24,619
2016	274	881	$27,896
2017	249	803	$25,418
2018	280	870	$28,906
2019	311	937	$33,727
2020	284	890	$33,135
2021	289	819	$29,902
2022	337	915	$29,806
2023	334	884	$36,294
2024	388	982	$31,552

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	60	$9,205
2016	16	46	$4,388
2017	N/R	47	$3,004
2018	N/R	30	$2,228
2019	N/R	16	$833
2020	N/R	31	$1,931
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
47563	Removal of gallbladder with x-ray study of bile ducts using an endoscope	17	17	$555
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	63	63	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	204	337	$88
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	31	31	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	150	205	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clenpiq	Sod Picosulf/Mag Ox/Citric Ac	52	111	$8,833
Synthroid	Levothyroxine Sodium	88	5,535	$7,329
Levothyroxine Sodium	Levothyroxine Sodium	374	27,636	$3,866
Cholestyramine	Cholestyramine (With Sugar)	14	555	$3,837
Fluorouracil	Fluorouracil	20	542	$1,192

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$169	Medical Device Business Services, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Harry Douglas Vildibill, M.D.?

Tedicare shows public-source Medicare data for Harry Douglas Vildibill, M.D. (NPI 1194702290), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harry Douglas Vildibill, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Harry Douglas Vildibill, M.D.?

Harry Douglas Vildibill, M.D. is linked to SURGICAL ASSOCIATES OF ALBANY PC (billing NPI 1447284781) in the available physician profile data.

Does Harry Douglas Vildibill, M.D. have Open Payments data?

Harry Douglas Vildibill, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.